Lenzilumab Antibody
Lenzilumab (KB 003) is a humanized monoclonal antibody designed to neutralize granulocyte-macrophage colony-stimulating factor (GM-CSF) by blocking its interaction with the receptor. It is utilized in research, including in vitro and in vivo studies, to investigate GM-CSF's role in inflammatory conditions such as COVID-19-associated hyperinflammation.
Product Specifications
Product Name Alternative
KB 003, KB003
Target
SARS-CoV, c-Fms
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology, Signal Transduction
Concentration
5.67 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
146.81 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6819703 1.0 µg DNA
Gfra1 sgRNA CRISPR Lentivector (Rat) (Target 2)
Sign In for Pricing
View Details